The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
about
IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifsCellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell ProcessesShigella IpaH Family Effectors as a Versatile Model for Studying Pathogenic BacteriaSubverting Toll-Like Receptor Signaling by Bacterial PathogensKilling two birds with one stone: trans-kingdom suppression of PAMP/MAMP-induced immunity by T3E from enteropathogenic bacteriaShigella: a model of virulence regulation in vivo.Structure and mechanism of a type III secretion protease, NleCModulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coliModulation of the host innate immune and inflammatory response by translocated bacterial proteinsMetalloprotease type III effectors that specifically cleave JNK and NF-κBThe enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factorsStructure and specificity of the bacterial cysteine methyltransferase effector NleE suggests a novel substrate in human DNA repair pathwayEnteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome ActivationModulation of NF-κB signalling by microbial pathogensBacteria fighting back: how pathogens target and subvert the host innate immune system.NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelAEnteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier functionRole of EscU auto-cleavage in promoting type III effector translocation into host cells by enteropathogenic Escherichia coliIdentification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion.Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements.EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function.Functional differences and interactions between the Escherichia coli type III secretion system effectors NleH1 and NleH2.Lysogeny with Shiga toxin 2-encoding bacteriophages represses type III secretion in enterohemorrhagic Escherichia coli.A Staphylococcus aureus TIR domain protein virulence factor blocks TLR2-mediated NF-κB signaling.Recent advances in understanding enteric pathogenic Escherichia coli.Recent advances in adherence and invasion of pathogenic Escherichia coliLack of effect of the Salmonella deubiquitinase SseL on the NF-κB pathway.The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection.Enteropathogenic and enterohemorrhagic Escherichia coli type III secretion effector EspV induces radical morphological changes in eukaryotic cells.Shigella IpaH0722 E3 ubiquitin ligase effector targets TRAF2 to inhibit PKC-NF-κB activity in invaded epithelial cells.Comparative analysis of super-shedder strains of Escherichia coli O157:H7 reveals distinctive genomic features and a strongly aggregative adherent phenotype on bovine rectoanal junction squamous epithelial cells.Microbial strategies for antagonizing Toll-like-receptor signal transduction.Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interactionAttaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation.Disruption of fas-fas ligand signaling, apoptosis, and innate immunity by bacterial pathogensA type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradationMolecular profiling of Escherichia coli O157:H7 and non-O157 strains isolated from humans and cattle in Alberta, Canada.Distinct mutations led to inactivation of type 1 fimbriae expression in Shigella sppMutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.
P2860
Q24297066-E453C2E8-3B9A-4FED-9AEF-2724CD536330Q24299272-F50D0B2E-DB2E-4600-BFE0-774DE60E9FAEQ26749369-B86E09BB-A7B5-4D7D-B1E3-27BF680428E3Q26771364-39F8D80E-3431-47CC-B21B-2DF9E9ECB4F6Q26773133-4CEB3E28-1FC9-4B92-806A-2722BD313E05Q26822456-005246A1-2655-4D44-8B48-B6B9412BAF44Q27687005-A395BA98-B357-4E87-9443-893592E1110FQ27688884-E18F1EAB-E938-4A18-BC61-3D10080EDE93Q28079739-6B23E5C0-6F58-4D33-B82C-C1AA374F7770Q28083042-1C2EFC3D-BF5F-435C-B1CB-50DB72497233Q28116010-0BD791C8-374F-43D0-AD51-2DF13FFEC647Q28478223-2F046DE9-FB1A-4E3F-88B7-5FC7F768B196Q28545104-94CCF91D-D9F5-417D-A885-78D8C6F74556Q28547711-EAB7589E-F47B-4B1B-8A44-2307E3C7B418Q28709497-6B1080B4-BEE6-49C4-91E4-6BC41B1393C0Q33623288-0123058C-470A-499A-BC8B-A12F823A406AQ33780981-17ACBD25-5ABE-4091-8EAE-53A8AF54DCA3Q33899677-C17D3108-7A31-4EB0-9250-50189665CD2BQ34024603-EF123F36-B421-49A3-B936-4CF462B8B4C6Q34082078-FBE9DE92-0736-40C0-A7C1-C88BD55CA5A9Q34177961-9C1A4FC4-BBAC-4505-A469-2F38C2D0309CQ34198962-798BDAB9-A907-4AA9-94FC-86485BD2E0B5Q34263876-C542CE57-EC5B-4B48-8564-DCF2A7BBA8E8Q34276994-1E7E1778-3260-47D4-8FE2-1B82C729339EQ34345726-2511B46D-08ED-4395-AD98-28976DB0AF04Q34375210-614C1660-4A44-40B3-9713-78C2B7FB19FDQ34429054-28E45923-E04F-44D8-9561-1DA36B3B7B8FQ34544660-2909014D-A6C8-4A23-9F59-84BD7D75DEC2Q34596147-5B960978-9A6B-436B-9CFD-3CBB60FDBCF5Q34739814-D5CFB221-D13C-424F-A363-9E661542B93AQ34765284-EF093DDE-00D3-4214-8094-10C5C6B15276Q35064271-EEC61BC5-A3B5-4607-8B47-55033BC1338DQ35108874-B9F19BF5-FBF9-48BA-B601-357AA966EF02Q35163621-5A89100E-CED2-43A8-BC2B-2EDB23B2F1A3Q35191956-1D0184B2-4EE3-47D7-A6E9-BDBDE9D3FB0DQ35220944-4DC21908-59C4-4BAB-B58E-BD8476578AD5Q35228516-12F5E84C-57EC-4222-9875-EFDD908A74A3Q35331334-2B8D6F98-07D5-4306-A3FD-A10A907819F2Q35587382-710AA7CA-6544-47F8-8B29-7F928DD8F3F9Q35925409-01AB74AA-D592-4B6C-B78E-00FB4A13F3CC
P2860
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@ast
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@en
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@nl
type
label
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@ast
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@en
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@nl
prefLabel
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@ast
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@en
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@nl
P2093
P2860
P50
P1433
P1476
The type III effectors NleE an ...... ranslocation of NF-kappaB p65.
@en
P2093
Alan D Phillips
Gavan Holloway
Jaclyn S Pearson
Joan Sloan
Luminita Badea
Mark Lucas
Michelle Kelly
P2860
P304
P356
10.1371/JOURNAL.PPAT.1000898
P50
P577
2010-05-13T00:00:00Z